Covera-hs and Prandin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Covera-hs (verapamil hydrochloride) and Prandin (repaglinide). Common drug interactions include anxiety among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Covera-hs and Prandin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Covera-hs?

Covera-hs has active ingredients of verapamil hydrochloride. eHealthMe is studying from 823 Covera-hs users. Check the latest studies of Covera-hs.

What is Prandin?

Prandin has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 4,680 Prandin users. Check the latest studies of Prandin.

On Jul, 07, 2026

18 people who take Covera-hs and Prandin together, and have interactions are studied.

Covera-hs and Prandin drug interactions.

What are the common drug interactions of Covera-Hs and Prandin, by gender? *:

female:

Anxiety
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthma
Back pain
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure congestive
Cardiac murmur (an heart sound in valve abnormality)
Cardiomegaly (increased size of heart than normal)

male:

Abdominal distension
Abdominal pain
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block first degree (heart block first degree)
Back pain
Balance disorder
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)

What are the common drug interactions of Covera-Hs and Prandin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Abdominal distension
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block first degree (heart block first degree)
Back pain

What are the existing conditions these people have? *

Metastatic Neoplasm (spreadable cancer tumour): 16 people, 88.89%
Breast Cancer Metastatic: 16 people, 88.89%
Hypersensitivity: 12 people, 66.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.56%
Metastases To Bone (cancer spreads to bone): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Covera-hs and Prandin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously